Jazz Pharmaceuticals plc — Director's Dealing 2012

Jan 13, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: JAZZ PHARMACEUTICALS INC (JAZZ)
CIK: 0001232524
Period of Report: 2012-01-11

Reporting Person: FALBERG KATHRYN E (SVP and CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-01-11	Common Stock	M	45580	$7.35	Acquired	49008	Direct
2012-01-11	Common Stock	F	24634	$48.60	Disposed	24374	Direct
2012-01-11	Common Stock	M	56250	$11.48	Acquired	80624	Direct
2012-01-11	Common Stock	F	33342	$48.60	Disposed	47282	Direct
2012-01-11	Common Stock	M	40000	$27.46	Acquired	87282	Direct
2012-01-11	Common Stock	F	29081	$48.60	Disposed	58201	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-01-11	Option (right to buy)	$7.35	M	45580	Disposed	2019-12-06	Common Stock (45580)	Direct
2012-01-11	Option (right to buy)	$11.48	M	56250	Disposed	2020-03-07	Common Stock (56250)	Direct
2012-01-11	Option (right to buy)	$27.46	M	40000	Disposed	2021-03-09	Common Stock (40000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	53000	Indirect

Footnotes

F1: Represents shares withheld by the Issuer for cashless exercise of nonstatutory stock options solely to cover exercise price and required withholding taxes.

F2: This option, consisting of a nonstatutory stock option exercisable for 45,580 shares of common stock and an incentive stock option exercisable for 54,420 shares of common stock, has a vesting schedule of one fourth vested on December 1, 2010 and the remainder vesting in 36 equal monthly installments thereafter.

F3: This option, consisting of a nonstatutory stock option exercisable for 56,250 shares of common stock and an incentive stock option exercisable for 3,750 shares of common stock, has a vesting schedule of one fourth vested on March 8, 2011 and the remainder vesting in 36 equal monthly installments thereafter.

F4: This nonstatutory stock option has a vesting schedule of one fourth vesting on March 1, 2012 and the remainder vesting in 36 equal monthly installments thereafter.

F5: On October 24, 2011, the Board of Directors of the Issuer approved the full vesting of unvested nonstatutory stock options held by the Issuer's officers and non-employee directors, including the Reporting Person. Such vesting acceleration became effective on December 13, 2011.